DE60137020D1 - Neue diphenylethylene-verbindungen - Google Patents

Neue diphenylethylene-verbindungen

Info

Publication number
DE60137020D1
DE60137020D1 DE60137020T DE60137020T DE60137020D1 DE 60137020 D1 DE60137020 D1 DE 60137020D1 DE 60137020 T DE60137020 T DE 60137020T DE 60137020 T DE60137020 T DE 60137020T DE 60137020 D1 DE60137020 D1 DE 60137020D1
Authority
DE
Germany
Prior art keywords
diphenyl ethylene
ethylene compounds
compounds
new diphenyl
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60137020T
Other languages
German (de)
English (en)
Inventor
Bishwajit Nag
Debendranath Dey
Satyanarayana Medicherla
Partha Neogi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Theracos Inc
Original Assignee
Theracos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/642,618 external-priority patent/US6624197B1/en
Application filed by Theracos Inc filed Critical Theracos Inc
Application granted granted Critical
Publication of DE60137020D1 publication Critical patent/DE60137020D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60137020T 2000-02-04 2001-02-05 Neue diphenylethylene-verbindungen Expired - Fee Related DE60137020D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18034000P 2000-02-04 2000-02-04
US09/642,618 US6624197B1 (en) 1998-05-08 2000-08-17 Diphenylethylene compounds
PCT/US2001/003797 WO2001056382A1 (en) 2000-02-04 2001-02-05 Novel diphenylethylene compounds

Publications (1)

Publication Number Publication Date
DE60137020D1 true DE60137020D1 (de) 2009-01-29

Family

ID=40157708

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60137020T Expired - Fee Related DE60137020D1 (de) 2000-02-04 2001-02-05 Neue diphenylethylene-verbindungen

Country Status (10)

Country Link
EP (1) EP1251738B1 (https=)
JP (1) JP2003521500A (https=)
CN (1) CN100484400C (https=)
AT (1) ATE417503T1 (https=)
AU (1) AU784974B2 (https=)
CA (1) CA2397076A1 (https=)
DE (1) DE60137020D1 (https=)
MX (1) MXPA02007514A (https=)
NZ (1) NZ520829A (https=)
WO (1) WO2001056382A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2356226C2 (ru) 2003-04-22 2009-05-27 Иэмди Кроп Байосайенс Кэнада Инк. Применение липохитоолигосахаридов для инициирования раннего цветения и развития плодов у растений
DE102004027912A1 (de) * 2004-06-09 2005-12-29 Grünenthal GmbH Substituierte Cyclopenten-Verbindungen
CN1723884A (zh) * 2004-07-21 2006-01-25 中国人民解放军军事医学科学院放射医学研究所 顺式－1，2－取代的二苯乙烯衍生物用于制备治疗或预防糖尿病的药物的用途
PL2519100T3 (pl) 2009-12-29 2017-09-29 Mapi Pharma Limited Związki pośrednie i sposoby wytwarzania tapentadolu i pokrewnych związków
CN117736099A (zh) * 2022-09-22 2024-03-22 中国科学院上海药物研究所 用于防治血管扩张性疾病的化合物及其制法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2524827A (en) * 1948-05-13 1950-10-10 Schering Corp Halogen substituted polycyclic aryl aliphatic acids
US5430062A (en) * 1992-05-21 1995-07-04 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents
AU669279B2 (en) * 1993-03-10 1996-05-30 Morinaga Milk Industry Company Limited Stilbene derivative and stilbene analog derivative, and use thereof
US5686478A (en) * 1993-07-20 1997-11-11 Merck & Co. Inc. Endothelin antagonists
TW325458B (en) * 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
JPH0959245A (ja) * 1995-08-25 1997-03-04 Yamanouchi Pharmaceut Co Ltd Ｎ−（２−プロペノイル）グアニジン誘導体
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
US6855726B1 (en) * 1998-03-31 2005-02-15 Warner-Lambert Company Llc Quinolones as serine protease inhibitors
US7105552B2 (en) * 1998-05-08 2006-09-12 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
JP2002544227A (ja) * 1999-05-18 2002-12-24 カリックス セラピューティックス インコーポレイテッド 新規ジフェニルエチレン化合物
US6413504B1 (en) * 2000-06-30 2002-07-02 Calyx Therapeutics, Inc. Alpha-arylated cinnamic esters and 1,4-bis(alpha-carboxyl-beta-styryl)benzene esters an UV-blocking agents

Also Published As

Publication number Publication date
EP1251738A1 (en) 2002-10-30
CN1437441A (zh) 2003-08-20
AU3333201A (en) 2001-08-14
ATE417503T1 (de) 2009-01-15
NZ520829A (en) 2004-12-24
AU784974B2 (en) 2006-08-10
EP1251738B1 (en) 2008-12-17
JP2003521500A (ja) 2003-07-15
CN100484400C (zh) 2009-05-06
MXPA02007514A (es) 2004-02-26
CA2397076A1 (en) 2001-08-09
EP1251738A4 (en) 2005-08-10
WO2001056382A1 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
BR9913932A (pt) Uso de análogos de glp-1 no tratamento de derrame
BRPI0408097A (pt) composição de insulina oral e processos para a produção e para o uso da mesma
Xiang et al. Transbuccal delivery of 2′, 3′-dideoxycytidine: in vitro permeation study and histological investigation
BR0113251A (pt) Compostos, composição cosmética, composição farmacêutica, uso cosmético de uma composição e uso de um composto
CA2238465A1 (fr) Composes triaromatiques, compositions les contenant et utilisations
BR9911076A (pt) Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica
BR0107535A (pt) Uso de carotenóides e forma de dosagem unitária destes
PT1545516E (pt) Formulação tópica compreendendo pelo menos 10% de metronidazole em vaselina branca e sua utilização na região anal e rectal
BRPI0407757A (pt) derivados de benzamida tetracìclica e métodos de uso dos mesmos
PT1035844E (pt) Utilizacao de poliois no combate a infeccoes por leveduras e preparacoes de poliol para a referida utilizacao
BR9812376A (pt) Uso de um pentopiranosil nucleosìdio para a produção de um componente eletronico, e seus conjugados
ES2170813T3 (es) Acidos 2,2-dicloroalcanocarboxilicos, proceso para su preparacion, medicamentos que los contienen y su uso para tratar la resistencia a la insulina.
BR0314898A (pt) Compostos, composição cosmética, uso cosmético de uma composição, uso de um composto e composição farmacêutica
EE05082B1 (et) Pürroolirea ühend, selle valmistamine ja kasutamine lipiidi- ja kolesteroolitaset alandava ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
BG106057A (en) Method of enhancing the efficacy of anti-tumour agents
BR0013353A (pt) Combinação de substância ativa com clonidina
AR025449A1 (es) Soluciones farmaceuticas de levosimendan
DK1377164T3 (da) Erythropoietin forbedrer kemoterapi-induceret toksicitet in vivo
CA2171675A1 (fr) Composes heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
DE60137020D1 (de) Neue diphenylethylene-verbindungen
IT1319210B1 (it) Pellicola per la somministrazione dermica e transdermica di principiattivi.
DK1035859T3 (da) Anvendelse af phospholipidkomplekser fra ekstrakter af Vitis vinifera som anti-atherosklerotiske midler
KR900016135A (ko) 피부 및 점막-상피의 질환 치료용 4-퀴놀린 카복실산 유도체
BR0015039A (pt) Método para administrar um inibidor fosfodiesterase 4

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee